Big Food Retools Products and Packs as GLP-1 Weight-Loss Drugs Reshape Demand
Food and beverage multinationals are shifting product formulations, package sizes and capital spending as rising use of GLP-1 appetite-suppressant drugs changes consumption patterns. Firms from PepsiCo to Kraft Heinz are accelerating innovation, increasing R&D and investing in protein- and fiber-forward offerings to adapt to smaller baskets and low…